45021
SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
May 25, 2021
China
East Asia and the Pacific
Apr 30, 2021
B - Limited
Active
Jul 1, 2021
Regional Industry - MAS Asia & Pac
other
Approved : May 4, 2021
Signed : May 25, 2021
Invested : Jun 29, 2021
other
Shanghai Fosun Pharmaceutical (Group) Co. Ltd., (“Fosun Pharma”, or the “Company”) is a leading manufacturer of pharmaceutical products and medical devices in China. The Company’s business spans across the healthcare value chain from research & development, pharmaceutical manufacturing, medical devices and diagnosis, to healthcare services, pharmaceutical distribution and retail. Fosun Pharma has been listed on the Shanghai Stock Exchange since 1998 and Hong Kong Stock Exchange since 2012.
The proposed IFC investment will primarily support Fosun Pharma’s manufacturing and distribution of COVID-19 related medical products, including the COVID-19 vaccine co-developed by Pfizer / BioNTech and COVID-19 testing kits and in China (the “Project”).
For Inquiries About the Project, Contact
For Inquiries and Comments About IFC, Contact
Local Access of Project Documentation
Environmental documents will be made accessible to locally affected communities.